Chargement en cours...
Conditional approval of cancer drugs in Canada: accountability and impact on public funding
BACKGROUND: We examined how conditional market approval of cancer pharmaceuticals by Health Canada (hc) affects public funding recommendations by the pan-Canadian Oncology Review (pcodr). We were also interested to see how often hc conditions are enforced. METHODS: Health Canada and pcodr databases...
Enregistré dans:
| Publié dans: | Curr Oncol |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Multimed Inc.
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6380633/ https://ncbi.nlm.nih.gov/pubmed/30853815 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.26.4397 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|